Total Payments
$34,072
2024 Payments
$257.05
Companies
11
Transactions
38
Medicare Patients
3,511
Medicare Billing
$260,642
Payment Breakdown by Category
Consulting$31,874 (93.5%)
Food & Beverage$1,413 (4.1%)
Travel$773.20 (2.3%)
Education$12.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,874 | 12 | 93.5% |
| Food and Beverage | $1,413 | 22 | 4.1% |
| Travel and Lodging | $773.20 | 3 | 2.3% |
| Education | $12.21 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Almirall LLC | $11,000 | 2 | $0 (2021) |
| Incyte Corporation | $9,173 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,695 | 9 | $0 (2019) |
| GENZYME CORPORATION | $5,073 | 2 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $2,080 | 1 | $0 (2020) |
| Lilly USA, LLC | $401.45 | 4 | $0 (2022) |
| ABBVIE INC. | $374.19 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $161.19 | 4 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $85.36 | 1 | $0 (2023) |
| Amgen Inc. | $16.65 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.05 | 6 | Novartis Pharmaceuticals Corporation ($161.19) |
| 2023 | $121.32 | 3 | Sun Pharmaceutical Industries Inc. ($85.36) |
| 2022 | $2,866 | 5 | Incyte Corporation ($2,625) |
| 2021 | $19,251 | 6 | Almirall LLC ($11,000) |
| 2020 | $5,540 | 5 | Incyte Corporation ($3,373) |
| 2019 | $6,010 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,695) |
| 2018 | $25.91 | 1 | AbbVie, Inc. ($25.91) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $129.03 | General |
| 08/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $82.10 | General |
| Category: Immunology | ||||||
| 05/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Dermatology | ||||||
| 03/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Dermatology | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 09/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $85.36 | General |
| Category: Dermatology | ||||||
| 11/08/2022 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 09/01/2022 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Education | In-kind items and services | $12.21 | General |
| Category: Monoclonal Antibody | ||||||
| 05/31/2022 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 05/26/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 05/11/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $103.93 | General |
| Category: Immunology | ||||||
| 12/10/2021 | Almirall LLC | — | Consulting Fee | Cash or cash equivalent | $9,600.00 | General |
| 12/04/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $4,991.00 | General |
| Category: Immunology | ||||||
| 07/07/2021 | Almirall LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 07/01/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $85.23 | General |
| Category: Immunology | ||||||
| 05/24/2021 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 03/08/2021 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 11/18/2020 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 07/09/2020 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $2,080.00 | General |
| 05/07/2020 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $2,458.00 | General |
| 02/20/2020 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| 01/08/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $87.29 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 884 | 1,685 | $263,714 | $64,888 |
| 2022 | 11 | 908 | 1,816 | $255,447 | $65,109 |
| 2021 | 11 | 887 | 1,605 | $265,023 | $73,816 |
| 2020 | 11 | 832 | 1,414 | $233,974 | $56,828 |
Total Patients
3,511
Total Services
6,520
Medicare Billing
$260,642
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 400 | $121,200 | $32,826 | 27.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 274 | $52,060 | $10,820 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 103 | $22,145 | $6,154 | 27.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 69 | 79 | $22,752 | $5,321 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 154 | 745 | $14,155 | $3,265 | 23.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 27 | $12,798 | $2,471 | 19.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 15 | 20 | $8,320 | $1,773 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,776 | $1,162 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $3,636 | $605.76 | 16.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 13 | $1,872 | $489.64 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 288 | 395 | $111,515 | $31,942 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 206 | 265 | $50,350 | $10,398 | 20.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 73 | 83 | $23,756 | $5,473 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 81 | $15,895 | $4,660 | 29.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 156 | 873 | $15,360 | $3,880 | 25.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 31 | 36 | $16,228 | $3,498 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,566 | $2,365 | 24.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 12 | 15 | $6,205 | $1,384 | 22.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $2,980 | $603.93 | 20.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 15 | $2,220 | $538.85 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,372 | $366.02 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 279 | 389 | $101,140 | $33,670 | 33.3% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 53 | 84 | $36,120 | $8,541 | 23.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 176 | 213 | $40,470 | $8,265 | 20.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 95 | $16,625 | $5,300 | 31.9% |
About Dr. Alan Fleischer, MD
Dr. Alan Fleischer, MD is a Dermatology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730165002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Fleischer, MD has received a total of $34,072 in payments from pharmaceutical and medical device companies, with $257.05 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($31,874).
As a Medicare-enrolled provider, Fleischer has provided services to 3,511 Medicare beneficiaries, totaling 6,520 services with total Medicare billing of $260,642. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Cincinnati, OH
- Active Since 12/19/2005
- Last Updated 07/24/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1730165002
Products in Payments
- DUPIXENT (Biological) $5,073
- TALTZ (Drug) $401.45
- Humira (Biological) $252.51
- Skyrizi (Biological) $88.61
- Winlevi (Drug) $85.36
- COSENTYX (Drug) $32.16
- SKYRIZI (Biological) $19.31
- Otezla (Drug) $16.65
- RINVOQ (Biological) $13.76
- POTELIGEO (Drug) $12.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Cincinnati
Mona Foad, Md, MD
Dermatology — Payments: $170,430
Dermatology $170,430
Bria Barjuca, Aprn-Cnp, APRN-CNP
Dermatology — Payments: $12,688
Dermatology $12,688
Dr. Drore Eisen, M.d, M.D
Dermatology — Payments: $10,499
Dermatology $10,499
Mona Mislankar, M.d, M.D
Dermatology — Payments: $8,503
Dermatology $8,503
Kristine Zitelli, M.d, M.D
Dermatology — Payments: $6,712
Dermatology $6,712
Debra Breneman, M. D, M. D
Dermatology — Payments: $5,957
Dermatology $5,957